We previously demonstrated that a novel 252-kDa protein (P252) isolated from brush border membranes (BBM) of Bombyx mori, hybrid ShureiϫShogetsu, specifically bound Cry1Aa, Cry1Ab and Cry1Ac toxins with a K d of 29, 179 and 20 nM, respectively. P252 was found in a Triton X-100-soluble fraction of BBM from first, third and fifth instar larvae, suggesting that it may be an important element of midgut epithelial cell membranes. P252 was not partitioned into a Triton X-100-insoluble BBM fraction and nearly identical partitioning of P252 was observed using detergents CHAPS and Igepal. These results suggested that P252 localized in non-raft regions of BBM. Immunofluorescence analysis using anti-P252 antiserum demonstrated the existence of P252 in BBMV. Cy3-labeled Cry1Aa, Cry1Ab and Cry1Ac were shown to bind to BBMV, and the addition of anti-P252 antiserum reduced the number of BBMV showing Cy3 fluorescence by 30%. This clearly suggested an important role for P252 in Cry1A binding to BBMV. CD spectra of a mixture of purified P252 with either Cry1Aa, Cry1Ab or Cry1Ac were compared with those of respective free Cry1A toxins and only one of the mixtures (Cry1Aa/P252) was shown to be significantly changed compared to that of native Cry1Aa.
INTRODUCTION
Cry1A toxins such as Cry1Aa, Cry1Ab, Cry1Ac etc; produced by Bacillus thuringiensis, are commonly used as insecticides.
Cadherin-like proteins (CadLP), with molecular masses of 170-180 or 210 kDa, have been proposed to act as receptors for Cry1A toxins in Manduca sexta (Vadlamudi et al., 1995) and Bombyx mori (Nagamatsu et al., 1998a (Nagamatsu et al., , b, 1999 . Recently, Gahan et al. (2001) discovered a Cry1Ac-resistant Heliothis virescens strain carrying a mutated CadLP gene. Hara et al. (2003) demonstrated that an antibody to CadLP (BtR175) inhibits the Cry1A toxin-mediated release of lactate dehydrogenase from midgut cells, thereby supporting the idea that CadLP may be a receptor for Cry1A toxins. Similarly, Gomez et al. (2001) reported that a phage display-derived peptide inhibits the specific binding between CadLP and Cry1Ab, whereas it did not disrupt the binding between aminopeptidase N (APN) and Cry1Ab.
Several reports support the "CadLP theory," which states that CadLP constitutes a receptor for Cry1A toxins, as mentioned above. However, prior to the proposal of this theory, several studies suggested that APN may in fact be the Cry1A toxin receptor (Knight et al., 1994; Martinez-Ramirez et al., 1994; Sangadala et al., 1994; Gill et al., 1995; Masson et al., 1995; Valaitis et al., 1995) . There is still uncertainty regarding the identity of the appropriate Cry1A receptor(s).
We recently discovered a 252-kDa protein (P252) from B. mori (hybrid of ShunreiϫShogetsu) brush border membrane vesicles (BBMV) that specifically bound Cy3-labeled Cry1Aa, Cry1Ab
Localization of a novel 252-kDa plasma membrane protein that binds Cry1A toxins in the midgut epithelia of Bombyx mori (Hossain et al., 2004) . These values represented substantial avidity and therefore suggested that P252 may bind Cry1A toxins under physiological conditions. P252 did not react with anti-APN or anti-BtR175 antiserums.
We investigated the characteristics of P252 to determine whether it constituted the true receptor for Cry1A toxins in this report. We first determined the detergent solubility of P252 in BBM, which suggested the localization of P252 in the non-raft region. Secondly, we used anti-P252 antiserum to check for the existence of this protein on the surface of BBMV. Thirdly, we studied the interaction of Cy3-labeled Cry1A toxins with BBMV. When anti-P252 antiserum was mixed with BBMV prior to the addition of Cy3-labeled toxins, the intensity of fluorescence on BBMV was significantly reduced. We discuss the significance of P252 localization on B. mori BBMV.
MATERIALS AND METHODS
Insect. The silkworm B. mori hybrid Shunreiϫ Shogetsu was reared on the artificial diet Silk Mate (Nosan Kogyo, Yokohama, Japan), and neonate, 1st, 3rd and 5th instar larvae were used in experiments.
Bacterial culture. B. thuringiensis was cultured for 3 d at 30°C using 500-ml baffled flasks containing 100 ml of NYS medium at 300 rpm in a rotary shaker (Suzuki et al., 1992) . Escherichia coli JM109 harboring pYD4.0, encoding the region of cry1Ab responsible for toxicity, was cultured for 48 h at 37°C in 100 ml of LB broth containing 50 mg/ml ampicillin (Kim et al., 1998) . The E. coli was a gift from Professor K. Kanda, Saga University.
Preparation of Cry1A toxins. Cry1Aa was prepared from B. thuringiensis sotto T84A1 (a gift from Professor M. Ohba, Kyushu University). B. thuringiensis kurstaki HD-73 was used to generate Cry1Ac. Cry1Ab was generated using transformed E. coli JM109 as described above. To purify Cry1A toxins, 100 ml of B. thuringiensis was cultured, and the alkali-soluble fraction containing Cry1Aa or Cry1Ac was prepared as described (Hossain et al., 2004) . A crystalline product from the transformed E. coli strain was obtained as described (Höfte et al., 1986; Lee et al., 1992 ) and solubilized as described above for the B. thuringiensis materials.
Activation of Cry1A toxins. The 130-kDa protoxins were activated with trypsin immobilized on Sepharose 4B as described previously (Indrasith et al., 1991) . The activated 60-kDa Cry1A toxins were fractionated using a 70 ml DEAE-Sepharose column in Tris-HCl (pH 8.3) with a 50-400 mM linear gradient of NaCl over 300 ml at 4°C.
Preparation of BBMV from B. mori. A total of 800 2 d-old 5th instar larvae of B. mori were dissected, and the isolated midguts were cut longitudinally to remove the peritrophic membrane. The samples were immersed in a volume of 0.1 ml for each midgut in pre-chilled buffer A (50 mM TrisHCl, pH 8.0, containing 5 mM EGTA and 300 mM mannitol), and midgut homogenate was produced as in Hossain et al. (2004) . The homogenate was resuspended and centrifuged at 1,000ϫg for 10 min at 4°C, and the supernatant was used to prepare BBMV as previously described (Wolfersberger et al., 1987) . For the detection of P252, BBMV were also prepared as above using midguts from other instar larvae. It is difficult to prepare BBMV from neonates, since the midgut is too small to fractionate, and therefore the whole midgut including the peritrophic membrane was homogenized in this case.
Solubilization of BBMV. A 700-ml suspension of BBMV was solubilized with gentle rotation at 4°C for 1 h in buffer A containing protease inhibitors as in Hossain et al. (2004) and either Triton X-100, CHAPS or Igepal at 1.5% or 0.5% (v/v) final concentration. Approximately 700 mg of soluble protein was recovered after ultracentrifugation at 100,000ϫg at 4°C for 1 h. Both soluble and insoluble fractions were analyzed using SDS-PAGE.
Preparation of P252 from B. mori BBM. Isolation and purification were performed as in Hossain et al. (2004) using Toyopearl HW 65, Sephacryl S-300 and DEAE Sepharose column chromatography.
Ligand blot analysis with Cry1A toxins. Proteins resolved by SDS-PAGE were transferred to a PVDF membrane at 2 mA/cm 2 of membrane for 2 h using an electric blotter. Membranes were blocked overnight using 1% skim milk in 150 mM PBST, pH 8.0, containing 0.13 M NaCl, 2.7 mM KCl and 0.05% (v/v) Tween 20.
Ligand blot analysis was performed to assay for Cry1Aa, Cry1Ab and Cry1Ac binding proteins as in Hossain et al. (2004) . Membrane-bound Cry1Aa and Cry1Ab were detected using rabbit antiCry1Aa, and Cry1Ac was detected using antiCry1Ac antisera. Toxin-bound antibodies were detected using peroxidase-conjugated goat anti-rabbit IgG (Amersham Biosciences, Piscataway, NJ, USA) and visualized using ECL reagents (Amersham Biosciences) and an LAS-3000 detector (Fujifilm Co. Ltd., Kanagawa, Japan).
Cy3 labeling of Cry1A. Activated Cry1A toxins (1 mg each) were labeled with the fluorescent dye, Cy3, as described by the manufacturer (Amersham Biosciences). DEAE column chromatography (bed volume ϳ2.5 ml) was used to separate non-reacted Cy3 (non-adsorbed) from labeled Cry1A toxins that were eluted with 50 mM Tris-HCl, pH 8.0, containing 300 mM NaCl. The purified labeled toxins were quantified using the Bradford (1976) method, and ϳ85% of the toxin was recovered in the Cy3-labeled fraction.
An aliquot of each purified labeled toxin was taken to measure fluorescence intensity with excitation at 550 nm and emission at 570 nm, and a calibration curve was produced to calculate protein concentration. The labeled toxins were used within 1 week following preparation due to inactivation of Cy3 via fluorescence quenching. A new calibration curve was produced for each newly synthesized labeled toxin.
Western blotting of P252 and preparation of P252 antiserum. Western blot analysis of P252 was performed using antibodies raised against family 1, 120-kDa APN (120K-APN) of B. mori (Nakanishi et al., 2002) and B. mori CadLP (BtR175). Detection of antibodies bound to P252 was achieved using peroxidase-conjugated goat anti-rabbit IgG or goat anti-mouse IgG, and bands were visualized using ECL. Recombinant 120K-APN and BTR175 were used as positive controls.
A 15-amino acid peptide was synthesized corresponding to an internal sequence of P252 (ATY-LAGSGGVVPVCN as previously determined; Hossain et al., 2004 ) and used to immunize rabbits.
Fluorescence microscopy of BBMV interacting with Cy3-labeled Cry1A (Cy3-Cry1A) or anti-P252. BBMV (60 mg protein for each treatment) were washed for 30 min with 150 mM PBS, pH 8.0 containing 0.13 M NaCl and 2.7 mM KCl and then blocked with the PBS containing 1% BSA for 1.5 h at 4°C with gentle shaking. BBMV in the blocking solution were centrifuged at 15,000ϫg for 15 min, and the pellet was resuspended and washed three times with PBS for 10 min each. Then, 60 mg of the BBMV was incubated individually with 100 mg of each Cy3-Cry1A toxin in PBS containing 0.5% BSA for 1 h at 4°C. The BBMV was then recovered by centrifugation at 15,000ϫg for 15 min at 4°C, and the pellet was rinsed with PBS three times for 10 min each. Finally, the pellet was resuspended in 40 ml PBS and suspended by sonication (TOCHO, UC-0515, Cho-Ompa Giken Co. Ltd., Tokyo, Japan) in a microcentrifuge tube. A 20-ml aliquot of the BBMV suspension was examined under a fluorescence microscope (BX60) equipped with a U-ULH Lens: UPlan F120 (Olympus Co. Ltd., Tokyo, Japan) and a CCD camera (U-CMAD3, Olympus).
P252 binding to BBMV was evaluated using anti-P252 antiserum diluted 1 : 1,000 in PBS and FITC-labeled secondary antibody (Amersham Biosciences) diluted 1 : 2,000 in PBS. To detect the inhibition of binding of Cy3-Cry1A toxins by anti-P252 antiserum, BBMV were treated with anti-P252 (1 : 100 dilution in PBS) for 1 h at 4°C prior to incubation with Cy3-Cry1A toxins. As a negative control, FITC labeled 2nd antibody or Cy3 were incubated with BBMV.
For Cy3 fluorescence microscopy, Cy3-Cry1A toxins were excited at 550 nm and emission was detected at 570 nm. FITC was excited at 450 nm and emission was detected at 510 nm. Fluorescence images were analyzed with computer-aided analytical software (DP 70, Olympus).
Protein quantification. Solubilized or chromatographed BBMV proteins were monitored by optical density at 280 nm and quantified by the Bradford method (Bradford, 1976) .
Circular dichroism spectroscopy. Far-UV circular dichroism (CD) experiments were performed with a spectropolarimeter (J-725, JASCO Co. Ltd., Tokyo, Japan) fitted with a 250-W xenon lamp. Spectra were recorded using cells with 0.1-cm light path at a speed of 50 nm/min over 190-260 nm. To calculate ellipticity, molecular weight of Cry1A toxins and P252 were considered as 69,000 and 252,000, respectively. Secondary structure estimation from CD spectra was performed as in Yang et al. (1986) . Equal molar concentrations (each 1 mM) of activated Cry1A toxins and purified P252 were co-incubated in 500 ml of 50 mM Tris-HCl, pH 8.0, containing 100 mM NaCl for 1 h at 25°C. CD spectra of mixtures of the respective Cry1A toxins with P252 were compared to that of each free Cry1A toxin.
RESULTS

Solubilization of BBMV with Triton X-100, CHAPS and Igepal
BBMV were prepared and solubilized with 0.1% Triton X-100 for 1 h at 4°C. P252 was detected only in the Triton X-100-soluble fraction (Fig. 1) . Under the same conditions, soluble and insoluble fractions of BBMVs from 1st, 3rd and 5th instar larvae were analyzed by SDS-PAGE (Fig. 2 , panel A and B) and P252 was shown to be partitioned to the detergent-soluble fraction using 0.5% or 1.5% of CHAPS and Igepal. Although the Coomassie brilliant blue staining of proteins of higher molecular weight is usually overestimated relative to lower molecular weight proteins, the staining of detergent-soluble P252 (Fig. 2, panel A) was comparable with proteins migrating at 90-120 kDa, including various proteins that bind Cry1A (120, 110, and 96 kDa). In contrast, detergent-insoluble fractions contained no P252 (Fig. 2, panel B) . P252 was observed in all larvae at the different stages assayed (Fig. 2, panel A) ; moreover, P252 was a dominant component even in neonates (data not shown). The patterns of BBMV proteins, detergent soluble and insoluble fractions obtained by three Fig. 1 . SDS-PAGE of P252 proteins from Bombyx mori. BBMV were prepared from 5th instar B. mori larvae and treated with 1% Triton X-100 for 1 h at 4°C to obtain detergent-soluble and -insoluble fractions by centrifugation at 100,000ϫg at 4°C for 1 h. SDS-PAGE was performed using a 7% gel and stained with Coomassie brilliant blue (CBB). Left lane: whole BBMV without detergent treatment. Center lane: Triton X-100-soluble fraction. Right lane: Triton X-100-insoluble fraction. Fig. 2 . SDS-PAGE of BBMV proteins in detergent-soluble and -insoluble fractions from larval midgut of Bombyx mori at different instars. BBMV were prepared from 1st, 3rd and 5th instars of B. mori larvae and treated with 1.5% and 0.5% (v/v) Triton X-100, CHAPS and Igepal for 1 h at 4°C, and detergent-soluble and -insoluble fractions were obtained by centrifugation at 100,000ϫg at 4°C for 1 h. SDS-PAGE was performed using a 7% gel that was stained with CBB. A: SDS-PAGE of detergent-soluble BBMV proteins. B: SDS-PAGE of detergent-insoluble proteins. The numbers above each gel indicate the detergent concentration used to solubilize BBMV proteins. Triton was defined as Triton X-100. different detergents were quite similar among larvae of 1st, 3rd and 5th instars (Fig. 2, panel A and  B) .
Cry1A toxin binding affinity for P252 and the 120-kDa aminopeptidase N (120K-APN) was analyzed using ligand blotting. BBMV from 5th instar larvae midgut, containing P252 and 120K-APN, were electrophoresed using SDS-PAGE, after which the separated proteins were transferred to a membrane. Membranes were then incubated with each Cry1A toxin at 180 mg/30 ml, a concentration that represented a vast excess compared to the quantity of P252 or 120K-APN used (20-30 mg of each protein).
The binding of the Cry1A toxins to P252 and 120K-APN was comparable in the respective detergent-soluble fractions (Fig. 3) .
Western blotting of P252
An antiserum to P252 was raised against a synthetic 15-amino acid internal peptide deduced from the sequence of P252 (Hossain et al., 2004) , and specific recognition of P252 was confirmed in western blots using BBMV proteins. The antiserum recognized P252 as well as proteins of 60, 80 and 140 kDa, and the binding intensity was similar among the latter three (Fig. 4, left panel) . However, only P252 interacted with Cry1A toxins in ligand blots (Fig.4, left panel) . P252 and a 120-kDa protein, solubilized from BBMV using either Triton X-100, CHAPS or Igepal, showed nearly identical immunoreactivity with anti-P252 and anti-120K-APN, respectively (Fig. 4, right panel) . Fig. 3 . Ligand blot analysis of P252 with Cry1A toxins. Purified P252 and cloned 120-kDa aminopeptidase N (120K) were electrophoresed using 7.5% SDS-PAGE gels and transferred onto a PVDF membrane. Both the gel (GEL) and the PVDF membrane (PVDF) were stained with CBB. About 20 mg of P252 and 30 mg of 120K APN were incubated with Cry1Aa, Cry1Ab and Cry1Ac, and toxin binding was visualized using anti-Cry1Aa and anti-Cry1Ac antiserum as described in Materials and Methods. The numbers above the lanes indicate the detergent concentration used in each case. Fig. 4 . Western blot analysis of purified P252 and 120-kDa aminopeptidase N with respective antisera. Detergent-soluble andinsoluble fractions from 5th instar B. mori were analyzed by western blots using anti-P252 and anti-120K-APN antiserum. A: Soluble and insoluble fractions were prepared from BBMV with 0.5% (v/v) Triton X-100. B: Detergent-soluble fractions prepared using various detergents (1.5% or 0.5% (v/v)) were analyzed with anti-P252 and anti-120K-APN antiserum.
Fluorescence microscopy of Cy3-Cry1A toxin binding to BBMV
As mentioned above, the three proteins that were recognized nonspecifically by anti-P252 (Fig. 4 , left panel, lane 5) were not recognized by Cry1Aa, Cry1Ab and Cry1Ac in ligand blot analyses. Therefore, anti-P252 antiserum seemed appropriate for use as an inhibitor of P252-Cry1A toxin binding. If, as expected, anti P252 antiserum reduces the binding, this would strongly suggest that P252 localizes to the BBMV surface and that the binding of Cry1A toxins to P252 is physiologically significant, at least in BBMV.
BBMV were incubated with anti-P252 antiserum for 1 h before the addition of individual Cry1A toxins. Anti-P252 antiserum bound to BBMV was detected using fluorescence microscopy with an FITC-labeled secondary antibody (Fig. 5) . Green fluorescence was observed in many of the BBMV(s), and the number of green fluorescent vesicles (Fig. 5, panel A) was always the same or slightly less compared with the number of BBMV observed in ordinary monotone light micrographs (Fig. 5, panel B) . This result clearly suggested that almost all BBMV(s) were labeled with anti-P252 antibody.
BBMV were incubated individually with Cy3-la- Comparison of circular dichroism (CD) spectra of the mixture of each Cry1A toxin and P252 with that of free respective Cry1A
In the studies above, the binding of Cy3-Cry1Aa to P252 seemed to differ from that of Cy3-Cry1Ab and -Cry1Ac with respect to the extent of inhibition by anti-P252 antisera (data not shown). This could reflect differences in the manner of binding between each Cry1A toxin and P252 on BBMV. Thus, we analyzed the change of CD spectra on mixing with P252 and Cry1A toxin. This spectrum did not show a net change of the respective toxins; instead it was affected by even P252 change in conformation on binding. Nonetheless, as shown, CD spectra obtained from native Cry1Aa and a mixture of P252/Cry1Aa were substantially different from each other and the differences at around 217-227 nm were the highest (Fig. 9) . The CD spectra at 218 and 223 nm reflect contents of bsheets and a-helices, respectively. The CD spectrum of free Cry1Ab was also different from that of a mixture of P252/Cry1Ab at 200 nm. The CD at 198 nm reflects contents of an a-helix. On the other hand, CD spectra of free Cry1Ac and a mixture of Cry1Ac/P252 were the same (Fig. 9) . The CD spectra at these specific wave lengths looked interfere each other with precise calculation of contents of these structures. However, there was a clear difference in the mode of interaction of Cry1Aa with P252 from that of Cry1Ac with P252. The contents of a-helices and b-sheets in Cry1Ac calculated with computer aided software remained indeed, unchanged on mixing with P252 (data not shown).
DISCUSSION
We recently identified the novel protein P252 in the BBM of B. mori, a hybrid of Shunreiϫ Shogetsu. P252 bound to Cry1Aa, Cry1Ab and Cry1Ac, and these interactions occurred under physiological conditions due to low K d values, and the binding was shown to be specific by heterologous competition assay (Hossain et al., 2004) . The fact that P252 from B. mori BBMV was solubilized with Triton X-100 suggested that it localized in non-raft regions of BBMV. In the present work, we focused on P252 localization and binding to Cry1A toxins.
The solubility of P252 in the nonionic detergent Triton X-100 suggested that it was not locating in a raft region of the plasma membrane, since raft proteins have been thought to be detergent insoluble (Hooper and Bashir, 1991) . This characteristic of P252 was confirmed using different detergent types such as CHAPS (zwitterionic) and Igepal (nonionic) (Fig. 2) . P252 was not detected in any detergent-insoluble fraction, therefore, P252 most likely did not localize to raft regions in the plasma membrane of B. mori midgut epithelial cells.
We visualized the localization of P252 on the surface of BBMV using anti-P252 antiserum and an FITC-labeled secondary antibody (Fig. 5) . We also showed that Cy3-labeled Cry1A toxins localized to BBMV (Figs. 6-8 ). These micrographs clearly suggested that P252 was located on the surface of BBMV and was involved in Cry1A toxin binding, as discussed below.
When BBMV were incubated with Cy3-Cry1A toxins, nearly the entire vesicle population exhibited Cy3 fluorescence. However, when BBMV were treated with diluted anti-P252 antiserum prior to the binding with Cry1A toxins, the fluorescence on BBMV(s) decreased to ϳ70% (an average of data for Cy3-Cry1Aa (Nϭ3), Cy3-Cry1Ab (Nϭ4) and Cy3-Cry1Ac (Nϭ3)). This decrease was slightly more pronounced for Cy3-Cry1Aa compared with Cy3-Cry1Ab and Cy3-Cry1Ac. Antiserum to P252, raised against an internal P252 peptide, recognized P252 as well as proteins of 60, 80 and 140 kDa in western blots. However, these unidentified cross-reacting proteins did not have affinity for Cry1Aa-c in ligand blots, and thus it was unlikely that they were involved in the reduction of Cy3-Cry1A-mediated fluorescence on BBMV(s).
Besides P252, there are many proteins on BBM that could bind Cry1A toxins, such as the 96-, 100-, 110-and 120-kDa proteins identified by Shitomi et al. (2001) as well as BtR175 (cadherin-like protein). These proteins were not recognized by our P252 antiserum in western blots. Therefore, if the population of these various proteins on BBMV is substantially higher than that of P252, then we would not have expected that anti-P252 antiserum would have significantly reduced Cy3-Cry1A-mediated fluorescence, given that the majority of the toxins would have remained associated with these other proteins. However, as stated above, anti-P252 antiserum reduced the fluorescence to an average of 70%, suggesting that the population of P252 may be significant relative to the total number of binding sites for Cry1Aa on at least some BBMV(s).
At this moment we don't have any evidence to support the above hypothesis but it would be possible that when midgut is homogenized to prepare BBMV according Wolfersberger's method, the plasma membrane once fragmented must be reconstructed to result the vesicles during salt-out processes with Mg 2ϩ . During these re-construction processes, raft and non-raft region or elements of those may assemble independently each other to form the BBMV based on physicochemical rules. Then, vesicles whose membrane contains P252 predominantly compared to other Cry1A bindingproteins will result. These BBMV(s) will not be detected in fluorescent microscope when they are treated with anti P252 antibody.
BBMV whose membrane was rich in various other binding proteins compared to P252 were counted as Cy3 fluorescent vesicle even after the treatment with anti P252 antiserum. Thus, if the above hypotheses are true, reduction of total fluorescence intensity must be higher than 30% as estimated from the number of non-fluorescent BBMV(s).
Anti-P252 antiserum reduced Cy3-Cry1Ac binding to BBMV to an extent equivalent to that observed for Cy3-Cry1Aa. We demonstrated that the binding of Cry1Ac/120K protein was very intense in ligand blots; furthermore, the prevalence of the 120K APN was high relative to other BBMV proteins (Fig. 4) . However, the reduction in the binding of Cy3-Cry1Ac to P252 by anti-P252 antiserum was nearly as high as for the other two toxins. It is not clear whether the high population and avid binding of 120K in the ligand blots are relevant in vivo, but our results suggested that the binding between Cy3-Cry1Ac and P252, like that between Cy3-Cry1Aa and P252, was physiologically significant.
We previously demonstrated the specificity of Cry1Ab binding to P252 although K d of 179 nM was relatively high compared with Cry1Aa and Cry1Ac. Interestingly, the sites on P252 that bind Cy3-Cry1Ab were shared with bovine serum albumin (Hossain et al., 2004) suggesting that these sites represented a common binding motif. Therefore, we compared the CD spectra obtained from a mixture of P252 with each Cry1A toxin to that of the free respective Cry1A toxins in expectation that the spectrum of a mixture of Cry1Ab/P252 should not differ from that of free Cry1Ab. The CD spectrum of the Cry1Aa-P252 mixture showed that an apparent conformational change occurred on the mixing, and minor conformational changes were also detected with the mixing of Cry1Ab with P252, but no change was observed when only P252 and Cry1Ac were mixed. Of course, a more accurate CD analysis would require an accurate estimation of the molecular weight of P252 as well as the number of binding sites for Cry1A toxins, neither of which has been fully established. Nonetheless, our data indicated that, under the same conditions, the mode of binding of Cry1Ab to P252 differed from that of Cry1Aa and Cry1Ac (Fig. 9) .
The present results suggest that the bindings between P252 and each of Cry1Aa, Cry1Ab and Cry1Ac are distinct. These binding characteristics warrant further investigation with regard to the functional significance of P252-Cry1A interactions. The most important direction for future research will be to determine whether P252 enhance the insecticidal effects of Cry1A toxins or inhibits as a trap for Cry1A toxins such as Cry1Ac. These will be effectively done using specific anti P252 anti serum and BBMV containing a fluorescence indicator like calcein. Liposome with lipid membrane containing P252 will also work well to determine the precise kinetics of pore formation by Cry1A toxins. The cloning of P252 is being undertaken in our laboratory using a eukaryotic expression system, and the protein will be introduced into a liposome to show detailed information about the interaction between P252 on lipid membrane and Cry1A toxins.
